[go: up one dir, main page]

TR201910467T4 - Selective PYY compounds and their uses. - Google Patents

Selective PYY compounds and their uses. Download PDF

Info

Publication number
TR201910467T4
TR201910467T4 TR2019/10467T TR201910467T TR201910467T4 TR 201910467 T4 TR201910467 T4 TR 201910467T4 TR 2019/10467 T TR2019/10467 T TR 2019/10467T TR 201910467 T TR201910467 T TR 201910467T TR 201910467 T4 TR201910467 T4 TR 201910467T4
Authority
TR
Turkey
Prior art keywords
pyy compounds
selective
selective pyy
compounds
pyy
Prior art date
Application number
TR2019/10467T
Other languages
Turkish (tr)
Inventor
Østergaard Søren
Waldemar Conde Frieboes Kilian
Wieczorek Birgit
Kaalby Thomsen Jens
Schjellerup Wulff Birgitte
Jessen Carsten
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of TR201910467T4 publication Critical patent/TR201910467T4/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)

Abstract

Mevcut buluş Peptit YY'nin (PYY) analogları ve/veya türevleri ve bunların farmasötik kullanımı ile ilgilidir.The present invention relates to analogs and / or derivatives of Peptide YY (PYY) and their pharmaceutical use.

TR2019/10467T 2013-11-15 2014-11-13 Selective PYY compounds and their uses. TR201910467T4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13193082 2013-11-15
US201361906020P 2013-11-19 2013-11-19
EP14176725 2014-07-11

Publications (1)

Publication Number Publication Date
TR201910467T4 true TR201910467T4 (en) 2019-08-21

Family

ID=67003096

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/10467T TR201910467T4 (en) 2013-11-15 2014-11-13 Selective PYY compounds and their uses.

Country Status (8)

Country Link
JP (1) JP2019189632A (en)
DK (1) DK3068421T3 (en)
ES (1) ES2732015T3 (en)
HR (1) HRP20191036T1 (en)
HU (1) HUE043900T2 (en)
PT (1) PT3068421T (en)
RU (1) RU2678312C1 (en)
TR (1) TR201910467T4 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7811989B2 (en) * 2003-01-17 2010-10-12 Ipsen Pharma S.A.S. Peptide YY analogs
JP2011520847A (en) * 2008-05-16 2011-07-21 ノボ・ノルデイスク・エー／エス Slow-acting Y2 and / or Y4 receptor agonist

Also Published As

Publication number Publication date
ES2732015T3 (en) 2019-11-20
DK3068421T3 (en) 2019-06-24
JP2019189632A (en) 2019-10-31
RU2678312C1 (en) 2019-01-25
PT3068421T (en) 2019-07-11
RU2016119121A (en) 2017-12-20
HRP20191036T1 (en) 2019-09-06
HUE043900T2 (en) 2019-09-30

Similar Documents

Publication Publication Date Title
CY1123953T1 (en) DELAYED RELEASE COMPOSITIONS OF LINACLOTIDE
CY1123633T1 (en) HETEROCYCLIC COMPOUNDS AND THEIR USES
MX386935B (en) PRODRUGS OF FUMARATES AND THEIR USE IN THE TREATMENT OF DIFFERENT DISEASES.
MX376869B (en) USEFUL METHODS IN THE SYNTHESIS OF HALICHONDRIN B ANALOGUES.
EA201891083A1 (en) COMPOSITIONS OF ANTIBODIES TO CD38 FOR SCRAPTURE AND THEIR APPLICATION
DOP2015000219A (en) HETEROARILO COMPOUNDS AND ITS USES
EA201591524A1 (en) DERIVATIVES 2-AMINOPYRIMIDINE FOR THE TREATMENT OF VIRAL INFECTIONS
MX378273B (en) ACTIVE COMPOUNDS TOWARDS BROMODOMAINS.
EA201692301A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201591887A1 (en) MACROCYCLIC DEAZAOXIPURINS FOR THE TREATMENT OF VIRAL INFECTIONS
MX2015011514A (en) HETEROARILO COMPOUNDS AND ITS USES.
MX2022011795A (en) P2X7 MODULATORS.
GT201400230A (en) NEEDS OF URACILO SPYROOXETHANE
CL2015003357A1 (en) 4'-Fluoro-2'-methyl substituted nucleoside derivatives
EA201591665A1 (en) ORAL STRUCTURES DEFERASYROX
EA201500383A1 (en) DERIVATIVES 1,2,4-TRIAZINE FOR THE TREATMENT OF VIRAL INFECTIONS
BR112015016930A2 (en) stabilized pharmaceutical formulations of insulin analogues and / or insulin derivatives
MX2015016495A (en) 3,4-DIHYDROISOQUINOLIN-2 (1H) -ILO COMPOUNDS.
EA201591712A1 (en) ANTIBIOTIC COMPOSITIONS BASED ON CEFTOLOSAN
EA201791454A1 (en) DRUG FORMS FOR TRANSDERMAL ADMINISTRATION
CR20160133A (en) SUBSTITUTED PHENYLALANINE DERIVATIVES
EA201791600A1 (en) DERIVATIVES OF HYDROXIALKILPIPERASINE AS RECESSOR CXCR3 MODULATORS
ECSP16096831A (en) DERIVATIVES OF NAPHTHYRIDINADIONA
CR20150417A (en) AZETIDINYLOXYPHENYLPIRROLIDINE COMPOUNDS
TR201901977T4 (en) (R) -2-methyl-piperazine derivatives as Cxcr3 receptor modulators.